logo

Defensive stocks from Switzerland.
By: StockWeb   Monday, January 07, 2008 7:13 PM

Vote for next session
The next market session will close:

 Yesterday I mentioned my investing strategy for current volatile market, putting money to defensive dividend stocks.And those companies are today's winners.

GlaxoSmithKline (GSK) was leading gains in London with +3.5%. Swiss market index SMI closed negative nevertheless large pharmaceutical and food caps were still attractive.

Nestle (NESN.VX) +2.19%,Roche (ROG.VX) +1.11% and Novartis (NVS) +1.15%.

Investment in Swiss market can be wise choice. Economy seems headed for its forth straight year of above trend growth. GDP for 2007 2.5% and outlook for 2008 is 2%. Risks for price stability remain on upside.

In context of lowering rates in US and Euro zone Swiss Franc should strengthen against both major currencies. This will bring you additional value for your investment. Franc is not seen as a funding currency for carry trades as it was in past. Switzerland continues to retain status as a safe heaven in recent sub prime mortgage crisis.

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by StockWeb



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia